GLP-1s and pregnancy: 5 things to know

An international panel of experts has published a systematic review and consensus guidelines on the use of incretin-based medications in women’s reproductive health, offering hospitals and clinicians recommendations for counseling patients before, during and after pregnancy, according to research published in Obesity Reviews. The panel reviewed 34 studies examining GLP-1s including semaglutide, liraglutide, dulaglutide, exenatide, […] The post GLP-1s and pregnancy: 5 things to know...